Skip to main content

The BIO CEO & Investor Conference program features issue-oriented business, policy, and therapeutic discussions.

Past speakers include MDs, CSOs and industry analysts discussing the latest information on pipeline innovation along with industry executives and analysts who delve into timely and relevant business models, deal-making, and investment trends.

Session topics include:

AI within Biopharma: Separating Value from Hype

Brain Health Discoveries: Neuropsychiatric Progress and New Cellular Maps

Market Outlook: Assessing Readiness for the Next IPO Window

Opportunities for Financing Your Company

Policy Outlook: Understanding Pricing and Access for Medicines

Recognizing the Patterns in Strategic M&A during Down Markets

Tackling Challenges in Oncology Drug Discovery

And more - check back soon for sessions and speakers.